A gut microbiota-independent mechanism shapes the bile acid pool in mice with MASH

Background & Aims: An imbalance between primary and secondary bile acids contributes to the development of metabolic dysfunction-associated steatohepatitis (MASH). The precise mechanisms underlying changes in the bile acid pool in MASH remain to be identified. As gut bacteria convert primary...

Full description

Saved in:
Bibliographic Details
Main Authors: Justine Gillard, Martin Roumain, Corinne Picalausa, Morgane M. Thibaut, Laure-Alix Clerbaux, Anne Tailleux, Bart Staels, Giulio G. Muccioli, Laure B. Bindels, Isabelle A. Leclercq
Format: Article
Language:English
Published: Elsevier 2024-11-01
Series:JHEP Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589555924001526
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850199092376895488
author Justine Gillard
Martin Roumain
Corinne Picalausa
Morgane M. Thibaut
Laure-Alix Clerbaux
Anne Tailleux
Bart Staels
Giulio G. Muccioli
Laure B. Bindels
Isabelle A. Leclercq
author_facet Justine Gillard
Martin Roumain
Corinne Picalausa
Morgane M. Thibaut
Laure-Alix Clerbaux
Anne Tailleux
Bart Staels
Giulio G. Muccioli
Laure B. Bindels
Isabelle A. Leclercq
author_sort Justine Gillard
collection DOAJ
description Background &amp; Aims: An imbalance between primary and secondary bile acids contributes to the development of metabolic dysfunction-associated steatohepatitis (MASH). The precise mechanisms underlying changes in the bile acid pool in MASH remain to be identified. As gut bacteria convert primary bile acids to secondary bile acids, we investigated the contribution of the gut microbiota and its metabolizing activities to bile acid alterations in MASH. Methods: To disentangle the influence of MASH from environmental and dietary factors, high-fat diet fed foz/foz mice were compared with their high-fat diet fed wildtype littermates. We developed functional assays (stable isotope labeling and in vitro experiments) to extend the analyses beyond a mere study of gut microbiota composition (16S rRNA gene sequencing). Key findings were confirmed in C57BL/6J mice were fed a Western and high-fructose diet, as an independent mouse model of MASH. Results: Although mice with MASH exhibited lower levels of secondary 7α-dehydroxylated bile acids (3.5-fold lower, p = 0.0008), the gut microbial composition was similar in mice with and without MASH. Similar gut microbial bile salt hydrolase and 7α-dehydroxylating activities could not explain the low levels of secondary 7α-dehydroxylated bile acids. Furthermore, the 7α-dehydroxylating activity was unaffected by Clostridium scindens administration in mice with a non-standardized gut microbiota. By exploring alternative mechanisms, we identified an increased bile acid 7α-rehydroxylation mediated by liver CYP2A12 and CYP2A22 enzymes (4.0-fold higher, p <0.0001), that reduces secondary 7α-dehydroxylated bile acid levels in MASH. Conclusions: This study reveals a gut microbiota-independent mechanism that alters the level of secondary bile acids and contributes to the development of MASH in mice. Impact and implications:: Although changes in bile acid levels are implicated in the development of metabolic dysfunction-associated steatohepatitis (MASH), the precise mechanisms underpinning these alterations remain elusive. In this study, we investigated the mechanisms responsible for the changes in bile acid levels in mouse models of MASH. Our results support that neither the composition nor the metabolic activity of the gut microbiota can account for the alterations in the bile acid pool. Instead, we identified hepatic 7α-rehydroxylation of secondary bile acids as a gut microbiota-independent factor contributing to the reduced levels of secondary bile acids in mice with MASH. Further investigation is warranted to understand bile acid metabolism and its physiological implications in clinical MASH. Nonetheless, our findings hold promise for exploring novel therapeutic interventions for MASH.
format Article
id doaj-art-8243d95a065e44218b65e8767a320ff1
institution OA Journals
issn 2589-5559
language English
publishDate 2024-11-01
publisher Elsevier
record_format Article
series JHEP Reports
spelling doaj-art-8243d95a065e44218b65e8767a320ff12025-08-20T02:12:42ZengElsevierJHEP Reports2589-55592024-11-0161110114810.1016/j.jhepr.2024.101148A gut microbiota-independent mechanism shapes the bile acid pool in mice with MASHJustine Gillard0Martin Roumain1Corinne Picalausa2Morgane M. Thibaut3Laure-Alix Clerbaux4Anne Tailleux5Bart Staels6Giulio G. Muccioli7Laure B. Bindels8Isabelle A. Leclercq9Laboratory of Hepato-Gastroenterology, Institute of Experimental and Clinical Research, Université Catholique de Louvain, Brussels, Belgium; Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, BelgiumBioanalysis and Pharmacology of Bioactive Lipids, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, BelgiumLaboratory of Hepato-Gastroenterology, Institute of Experimental and Clinical Research, Université Catholique de Louvain, Brussels, BelgiumMetabolism and Nutrition Research Group, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, BelgiumLaboratory of Hepato-Gastroenterology, Institute of Experimental and Clinical Research, Université Catholique de Louvain, Brussels, BelgiumUniversity of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, Lille, FranceUniversity of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, Lille, FranceBioanalysis and Pharmacology of Bioactive Lipids, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, BelgiumMetabolism and Nutrition Research Group, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium; Welbio department, WEL Research Institute, Wavre, BelgiumLaboratory of Hepato-Gastroenterology, Institute of Experimental and Clinical Research, Université Catholique de Louvain, Brussels, Belgium; Corresponding author. Address: Avenue Mounier 53/B1.52.01, 1200 Woluwe-Saint-Lambert, Belgium. Tel: +32 2 764 52 73.Background &amp; Aims: An imbalance between primary and secondary bile acids contributes to the development of metabolic dysfunction-associated steatohepatitis (MASH). The precise mechanisms underlying changes in the bile acid pool in MASH remain to be identified. As gut bacteria convert primary bile acids to secondary bile acids, we investigated the contribution of the gut microbiota and its metabolizing activities to bile acid alterations in MASH. Methods: To disentangle the influence of MASH from environmental and dietary factors, high-fat diet fed foz/foz mice were compared with their high-fat diet fed wildtype littermates. We developed functional assays (stable isotope labeling and in vitro experiments) to extend the analyses beyond a mere study of gut microbiota composition (16S rRNA gene sequencing). Key findings were confirmed in C57BL/6J mice were fed a Western and high-fructose diet, as an independent mouse model of MASH. Results: Although mice with MASH exhibited lower levels of secondary 7α-dehydroxylated bile acids (3.5-fold lower, p = 0.0008), the gut microbial composition was similar in mice with and without MASH. Similar gut microbial bile salt hydrolase and 7α-dehydroxylating activities could not explain the low levels of secondary 7α-dehydroxylated bile acids. Furthermore, the 7α-dehydroxylating activity was unaffected by Clostridium scindens administration in mice with a non-standardized gut microbiota. By exploring alternative mechanisms, we identified an increased bile acid 7α-rehydroxylation mediated by liver CYP2A12 and CYP2A22 enzymes (4.0-fold higher, p <0.0001), that reduces secondary 7α-dehydroxylated bile acid levels in MASH. Conclusions: This study reveals a gut microbiota-independent mechanism that alters the level of secondary bile acids and contributes to the development of MASH in mice. Impact and implications:: Although changes in bile acid levels are implicated in the development of metabolic dysfunction-associated steatohepatitis (MASH), the precise mechanisms underpinning these alterations remain elusive. In this study, we investigated the mechanisms responsible for the changes in bile acid levels in mouse models of MASH. Our results support that neither the composition nor the metabolic activity of the gut microbiota can account for the alterations in the bile acid pool. Instead, we identified hepatic 7α-rehydroxylation of secondary bile acids as a gut microbiota-independent factor contributing to the reduced levels of secondary bile acids in mice with MASH. Further investigation is warranted to understand bile acid metabolism and its physiological implications in clinical MASH. Nonetheless, our findings hold promise for exploring novel therapeutic interventions for MASH.http://www.sciencedirect.com/science/article/pii/S2589555924001526Bile acidsEnterohepatic cycle7α-Dehydroxylation7α-RehydroxylationGut microbiotaClostridium scindens
spellingShingle Justine Gillard
Martin Roumain
Corinne Picalausa
Morgane M. Thibaut
Laure-Alix Clerbaux
Anne Tailleux
Bart Staels
Giulio G. Muccioli
Laure B. Bindels
Isabelle A. Leclercq
A gut microbiota-independent mechanism shapes the bile acid pool in mice with MASH
JHEP Reports
Bile acids
Enterohepatic cycle
7α-Dehydroxylation
7α-Rehydroxylation
Gut microbiota
Clostridium scindens
title A gut microbiota-independent mechanism shapes the bile acid pool in mice with MASH
title_full A gut microbiota-independent mechanism shapes the bile acid pool in mice with MASH
title_fullStr A gut microbiota-independent mechanism shapes the bile acid pool in mice with MASH
title_full_unstemmed A gut microbiota-independent mechanism shapes the bile acid pool in mice with MASH
title_short A gut microbiota-independent mechanism shapes the bile acid pool in mice with MASH
title_sort gut microbiota independent mechanism shapes the bile acid pool in mice with mash
topic Bile acids
Enterohepatic cycle
7α-Dehydroxylation
7α-Rehydroxylation
Gut microbiota
Clostridium scindens
url http://www.sciencedirect.com/science/article/pii/S2589555924001526
work_keys_str_mv AT justinegillard agutmicrobiotaindependentmechanismshapesthebileacidpoolinmicewithmash
AT martinroumain agutmicrobiotaindependentmechanismshapesthebileacidpoolinmicewithmash
AT corinnepicalausa agutmicrobiotaindependentmechanismshapesthebileacidpoolinmicewithmash
AT morganemthibaut agutmicrobiotaindependentmechanismshapesthebileacidpoolinmicewithmash
AT laurealixclerbaux agutmicrobiotaindependentmechanismshapesthebileacidpoolinmicewithmash
AT annetailleux agutmicrobiotaindependentmechanismshapesthebileacidpoolinmicewithmash
AT bartstaels agutmicrobiotaindependentmechanismshapesthebileacidpoolinmicewithmash
AT giuliogmuccioli agutmicrobiotaindependentmechanismshapesthebileacidpoolinmicewithmash
AT laurebbindels agutmicrobiotaindependentmechanismshapesthebileacidpoolinmicewithmash
AT isabellealeclercq agutmicrobiotaindependentmechanismshapesthebileacidpoolinmicewithmash
AT justinegillard gutmicrobiotaindependentmechanismshapesthebileacidpoolinmicewithmash
AT martinroumain gutmicrobiotaindependentmechanismshapesthebileacidpoolinmicewithmash
AT corinnepicalausa gutmicrobiotaindependentmechanismshapesthebileacidpoolinmicewithmash
AT morganemthibaut gutmicrobiotaindependentmechanismshapesthebileacidpoolinmicewithmash
AT laurealixclerbaux gutmicrobiotaindependentmechanismshapesthebileacidpoolinmicewithmash
AT annetailleux gutmicrobiotaindependentmechanismshapesthebileacidpoolinmicewithmash
AT bartstaels gutmicrobiotaindependentmechanismshapesthebileacidpoolinmicewithmash
AT giuliogmuccioli gutmicrobiotaindependentmechanismshapesthebileacidpoolinmicewithmash
AT laurebbindels gutmicrobiotaindependentmechanismshapesthebileacidpoolinmicewithmash
AT isabellealeclercq gutmicrobiotaindependentmechanismshapesthebileacidpoolinmicewithmash